These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1973751)

  • 1. Mechanisms involved in the development of adriamycin resistance in human leukemic cells.
    Kato S; Ideguchi H; Muta K; Nishimura J; Nawata H
    Leuk Res; 1990; 14(6):567-73. PubMed ID: 1973751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
    de Jong S; Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
    Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
    Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide.
    Hosking LK; Whelan RD; Shellard SA; Davies SL; Hickson ID; Danks MK; Hill BT
    Int J Cancer; 1994 Apr; 57(2):259-67. PubMed ID: 7908897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.
    Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT
    J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
    Hill BT; van der Graaf WT; Hosking LK; de Vries EG; Mulder NH; Whelan RD
    Int J Cancer; 1993 Sep; 55(2):330-7. PubMed ID: 8103761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
    Hill BT; Whelan RD; Hurst HC; McClean S
    Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of correlation between cytotoxicity and drug transport by P-glycoprotein in clinical leukemic cells.
    Kato S; Ideguchi H; Muta K; Nishimura J; Nawata H
    Eur J Haematol; 1991 Aug; 47(2):146-51. PubMed ID: 1679720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
    Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.
    Souès S; Laval F; Charcosset JY
    Br J Cancer; 1995 Mar; 71(3):489-97. PubMed ID: 7880729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.
    McGrath T; Latoud C; Arnold ST; Safa AR; Felsted RL; Center MS
    Biochem Pharmacol; 1989 Oct; 38(20):3611-9. PubMed ID: 2573357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
    Lee WP; Lee CL; Kao MC
    Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
    Zwelling LA; Slovak ML; Doroshow JH; Hinds M; Chan D; Parker E; Mayes J; Sie KL; Meltzer PS; Trent JM
    J Natl Cancer Inst; 1990 Oct; 82(19):1553-61. PubMed ID: 1976136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.